The role of myristoylation in the membrane association of the Lassa virus matrix protein Z

Virology Journal

Volumn 3, Issue , 2006, Pages

  Strecker, Thomas ^a   Maisa, Anna ^a   Daffis, Stephane ^a,b   Eichler, Robert ^a,c   Lenz, Oliver ^a,d   Garten, Wolfgang ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ABBOTT GMBH AND CO KG   (Germany)

^d TIBOTEC BVBA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

13 OXAMYRISTIC ACID; 4 OXATETRADECANOIC ACID; ALANINE; DECANOIC ACID DERIVATIVE; FATTY ACID BINDING PROTEIN; GLYCINE; MATRIX PROTEIN; MYRISTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LASSA VIRUS; MEMBRANE BINDING; MYRISTYLATION; NONHUMAN; PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; VIRUS INHIBITION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; HUMANS; LASSA VIRUS; MUTATION; MYRISTIC ACID; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; VERO CELLS; VIRAL MATRIX PROTEINS;

LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 33751162632     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-93     Document Type: Article

References (49)

1. Auperin DD, Sasso DR, McCormick JB: Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 1986, 154(1):155-167.
2. Clegg JC, Oram JD: Molecular cloning of Lassa virus RNA: nucleotide sequence and expression of the nucleocapsid protein gene. Virology 1985, 144(2):363-372.
3. Eichler R, Lenz O, Strecker T, Eickmann M, Klenk HD, Garten W: Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep 2003, 4(11):1084-1088.
4. Eichler R, Lenz O, Strecker T, Garten W: Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 2003, 538(1-3):203-206.
5. Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W: The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A 2001, 98(22):12701-12705.
6. Djavani M, Lukashevich IS, Sanchez A, Nichol ST, Salvato MS: Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′ End. Virology 1997, 235(2):414-418.
7. Lukashevich IS, Djavani M, Shapiro K, Sanchez A, Ravkov E, Nichol ST, Salvato MS: The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. J Gen Virol 1997, 78 ( Pt 3):547-551.
8. Borden KL, Campbell Dwyer EJ, Salvato MS: An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 1998, 72(1):758-766.
9. Borden KL, Campbelldwyer EJ, Carlile GW, Djavani M, Salvato MS: Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 1998, 72(5):3819-3826.
10. Campbell Dwyer EJ, Lai H, MacDonald RC, Salvato MS, Borden KL: The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J Virol 2000, 74(7):3293-3300.
11. Cornu TI, Feldmann H, de la Torre JC: Cells expressing the RING finger Z protein are resistant to arenavirus infection. J Virol 2004, 78(6):2979-2983.
12. Cornu TI, de la Torre JC: RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J Virol 2001, 75(19):9415-9426.
13. Salvato MS, Schweighofer KJ, Burns J, Shimomaye EM: Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res 1992, 22(3):185-198.
14. Perez M, Craven RC, de la Torre JC: The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 2003, 100(22):12978-12983.
15. Strecker T, Eichler R, Meulen J, Weissenhorn W, Dieter Klenk H, Garten W, Lenz O: Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 2003, 77(19):10700-10705.
16. Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O: Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 2004, 100(2):249-255.
17. Perez M, Greenwald DL, de la Torre JC: Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol 2004, 78(20):11443-11448.
18. Cordo SM, Candurra NA, Damonte EB: Myristic acid analogs are inhibitors of Junin virus replication. Microbes Infect 1999, 1(8):609-614.
19. Farazi TA, Waksman G, Gordon JI: The biology and enzymology of protein N-myristoylation. J Biol Chem 2001, 276(43):39501-39504.
20. Boutin JA: Myristoylation. Cell Signal 1997, 9(1):15-35.
21. de Jonge HR, Hogema B, Tilly BC: Protein N-myristoylation: critical role in apoptosis and salt tolerance. Sci STKE 2000, 2000(63):PE1.
22. Resh MD: Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999, 1451(1):1-16.
23. Resh MD: Membrane targeting of lipid modified signal transduction proteins. Subcell Biochem 2004, 37:217-232.
24. Taniguchi H: Protein myristoylation in protein-lipid and protein-protein interactions. Biophys Chem 1999, 82(2-3):129-137.
25. Grand RJ: Acylation of viral and eukaryotic proteins. Biochem J 1989, 258(3):625-638.
26. Harper DR, Gilbert RL: Viral lipoproteins: the role of myristoylation. Biochem Soc Trans 1995, 23(3):553-557.
27. Maurer-Stroh S, Eisenhaber F: Myristoylation of viral and bacterial proteins. Trends Microbiol 2004, 12(4):178-185.
28. Bryant M, Ratner L: Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci U S A 1990, 87(2):523-527.
29. Bryant ML, Heuckeroth RO, Kimata JT, Ratner L, Gordon JI: Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A 1989, 86(22):8655-8659.
30. Gottlinger HG, Sodroski JG, Haseltine WA: Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1989, 86(15):5781-5785.
31. Harper DR, Gilbert RL, Blunt C, McIlhinney RA: Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation. J Gen Virol 1993, 74 ( Pt 6):1181-1184.
32. Krausslich HG, Holscher C, Reuer Q, Harber J, Wimmer E: Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J Virol 1990, 64(5):2433-2436.
33. Marc D, Girard M, van der Werf S: A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly. J Gen Virol 1991, 72 ( Pt 5):1151-1157.
34. Moscufo N, Simons J, Chow M: Myristoylation is important at multiple stages in poliovirus assembly. J Virol 1991, 65(5):2372-2380.
35. Pal R, Reitz MS Jr., Tschachler E, Gallo RC, Sarngadharan MG, Veronese FD: Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res Hum Retroviruses 1990, 6(6):721-730.
36. Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM: Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A 1986, 83(19):7246-7250.
37. Yonemoto W, McGlone ML, Taylor SS: N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability. J Biol Chem 1993, 268(4):2348-2352.
38. Buss JE, Kamps MP, Gould K, Sefton BM: The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. J Virol 1986, 58(2):468-474.
39. Jones TL, Simonds WF, Merendino JJ Jr., Brann MR, Spiegel AM: Myristoylation of an inhibitory GTP-binding protein alpha subunit is essential for its membrane attachment. Proc Natl Acad Sci U S A 1990, 87(2):568-572.
40. Parang K, Wiebe LI, Knaus EE, Huang JS, Tyrrell DL, Csizmadia F: In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses. Antiviral Res 1997, 34(3):75-90.
41. Langner CA, Lodge JK, Travis SJ, Caldwell JE, Lu T, Li Q, Bryant ML, Devadas B, Gokel GW, Kobayashi GS, et al.: 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. J Biol Chem 1992, 267(24):17159-17169.
42. Lindwasser OW, Resh MD: Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc Natl Acad Sci U S A 2002, 99(20):13037-13042.
43. Silverman L, Resh MD: Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src. J Cell Biol 1992, 119(2):415-425.
44. Welker R, Harris M, Cardel B, Krausslich HG: Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J Virol 1998, 72(11):8833-8840.
45. Zhou W, Parent LJ, Wills JW, Resh MD: Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 1994, 68(4):2556-2569.
46. Hermida-Matsumoto L, Resh MD: Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 2000, 74(18):8670-8679.
47. York J, Romanowski V, Lu M, Nunberg JH: The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J Virol 2004, 78(19):10783-10792.
48. Lenz O, ter Meulen J, Feldmann H, Klenk HD, Garten W: Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol 2000, 74(23):11418-11421.
49. Eichler R, Lenz O, Strecker T, Eickmann M, Klenk HD, Garten W: Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region. J Biol Chem 2004, 279(13):12293-12299.